<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31919375</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The potential of neurofilaments analysis using dry-blood and plasma spots.</ArticleTitle><Pagination><StartPage>97</StartPage><MedlinePgn>97</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">97</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-54310-y</ELocationID><Abstract><AbstractText>The lack of biomarkers for an early diagnosis of neurodegenerative disorders (NDs) has hampered the development of therapeutics whose effect would be enhanced by a timely intervention. Neurofilaments light chain (Nf-L), an integral part of the axonal structure, has emerged as a robust fluid biomarker for fatal neurodegenerative disorders like amyotrophic lateral sclerosis (ALS). To facilitate large-scale studies into early-stage neurodegeneration, reduce costs of samples collection/processing and cold-chain storage, we describe the measurement of Nf-L in blood fractions obtained from dry blood spots (DBS) and dry plasma spots (DPS), two filter paper-based remote blood collection tools. To test the feasibility of using this approach, Nf-L analysis in DBS/DPS is compared to that in plasma obtained from the same blood sample, looking at Nf-L discriminatory power in the clinical stratification of ALS compared to healthy controls. With the best pre-analytical treatment for total protein recovery and using highly sensitive immunoassays, we report the detection of different Nf-L levels in DBS elute compared to reference plasma and DPS from the same blood samples. However, Nf-L measurement in DBS elutes provides a very good discrimination of ALS from healthy controls which is comparable to that obtained using plasma Nf-L assays. With the available immunodetection methods, we show that Nf-L measurement based on DPS microsampling is similar to that in plasma. The filter-paper biophysical characteristics and the interference of high haemoglobin concentration released by erythrocyte lysis is likely to perturb Nf-L detection in DBS elute. Further studies into DBS-based Nf-L detection and its analytical optimization are needed to make this method suitable for routine Nf-L blood analyses in neurodegeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Vittoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Blizard Institute, Queen Mary, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carassiti</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1664-4324</Identifier><AffiliationInfo><Affiliation>Blizard Institute, Queen Mary, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giovannoni</LastName><ForeName>Gavin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Blizard Institute, Queen Mary, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ching-Hua</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-5191-5089</Identifier><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adiutori</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Blizard Institute, Queen Mary, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malaspina</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Blizard Institute, Queen Mary, University of London, London, UK. a.malaspina@qmul.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MALASPINA/APR13/817-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>TURNER/OCT15/972-797</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>U54 NS092091</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>17-CReA-382</GrantID><Agency>Amyotrophic Lateral Sclerosis Association (ALS Association)</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016900">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C044882">neurofilament protein L</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Sci Rep. 2020 Jun 26;10(1):10774</RefSource><PMID Version="1">32587334</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001800" MajorTopicYN="N">Blood Specimen Collection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059788" MajorTopicYN="N">Dried Blood Spot Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016900" MajorTopicYN="N">Neurofilament Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013048" MajorTopicYN="N">Specimen Handling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31919375</ArticleId><ArticleId IdType="pmc">PMC6952412</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-54310-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-54310-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fineberg NA, et al. The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol. 2013;27:761&#x2013;770. doi: 10.1177/0269881113495118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881113495118</ArticleId><ArticleId IdType="pmc">PMC3778981</ArticleId><ArticleId IdType="pubmed">23884863</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan, A. T. et al. Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer&#x2019;s Disease: A Judicious Update. Front Aging Neurosci9, ARTN 35610.3389/fnagi.2017.00356 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5671974</ArticleId><ArticleId IdType="pubmed">29163138</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaiottino J, et al. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One. 2013;8:e75091. doi: 10.1371/journal.pone.0075091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075091</ArticleId><ArticleId IdType="pmc">PMC3779219</ArticleId><ArticleId IdType="pubmed">24073237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Haces, M., Tang, J., Acosta, G., Fernandez, J. &amp; Shi, R. Y. Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases. Transl Neurodegener6, ARTN 2010.1186/s40035-017-0088-2 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504572</ArticleId><ArticleId IdType="pubmed">28702179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H, Blennow K. From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer&#x2019;s Disease. J Alzheimers Dis. 2018;64:S271&#x2013;S279. doi: 10.3233/JAD-179926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-179926</ArticleId><ArticleId IdType="pubmed">29758941</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, et al. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 2015;84:2247&#x2013;2257. doi: 10.1212/WNL.0000000000001642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001642</ArticleId><ArticleId IdType="pmc">PMC4456658</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, et al. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer&#x2019;s disease: a systematic review. BMC Geriatr. 2016;16:104. doi: 10.1186/s12877-016-0281-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-016-0281-7</ArticleId><ArticleId IdType="pmc">PMC4869390</ArticleId><ArticleId IdType="pubmed">27184250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson DH, et al. The Simoa HD-1 Analyzer: A Novel Fully Automated Digital Immunoassay Analyzer with Single-Molecule Sensitivity and Multiplexing. J Lab Autom. 2016;21:533&#x2013;547. doi: 10.1177/2211068215589580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2211068215589580</ArticleId><ArticleId IdType="pubmed">26077162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle J, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016;54:1655&#x2013;1661. doi: 10.1515/cclm-2015-1195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2015-1195</ArticleId><ArticleId IdType="pubmed">27071153</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoni E, et al. Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis. Sci Rep. 2019;9:4478. doi: 10.1038/s41598-019-40632-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40632-4</ArticleId><ArticleId IdType="pmc">PMC6418138</ArticleId><ArticleId IdType="pubmed">30872628</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinson P. Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers. EJIFCC. 2015;26:183&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4975302</ArticleId><ArticleId IdType="pubmed">27683493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim MD. Dried Blood Spots for Global Health Diagnostics and Surveillance: Opportunities and Challenges. Am J Trop Med Hyg. 2018;99:256&#x2013;265. doi: 10.4269/ajtmh.17-0889.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.17-0889</ArticleId><ArticleId IdType="pmc">PMC6090344</ArticleId><ArticleId IdType="pubmed">29968557</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta K, Mahajan R. Applications and Diagnostic Potential of Dried Blood Spots. Int J Appl Basic Med Res. 2018;8:1&#x2013;2. doi: 10.4103/ijabmr.IJABMR_7_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijabmr.IJABMR_7_18</ArticleId><ArticleId IdType="pmc">PMC5846211</ArticleId><ArticleId IdType="pubmed">29552526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis (vol 84, pg 2247, 2015) Neurology. 2015;85:921&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4456658</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewczuk, P. et al. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer&#x2019;s disease. Alzheimers Res Ther10, ARTN 7110.1186/s13195-018-0404-9 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6064615</ArticleId><ArticleId IdType="pubmed">30055655</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa OR, et al. An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65. PLoS One. 2018;13:e0193670. doi: 10.1371/journal.pone.0193670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0193670</ArticleId><ArticleId IdType="pmc">PMC5843250</ArticleId><ArticleId IdType="pubmed">29518118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, et al. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcdade TW, Williams S, Snodgrass JJ. What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography. 2007;44:899&#x2013;925. doi: 10.1353/dem.2007.0038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/dem.2007.0038</ArticleId><ArticleId IdType="pubmed">18232218</ArticleId></ArticleIdList></Reference><Reference><Citation>Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs (vol 2, pg 1385, 2010) Bioanalysis. 2011;3:818&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">21083339</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers AG, Percy AJ, Hardie DB, Borchers CH. Comparison of proteins in whole blood and dried blood spot samples by LC/MS/MS. J Am Soc Mass Spectrom. 2013;24:1338&#x2013;1345. doi: 10.1007/s13361-013-0678-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13361-013-0678-x</ArticleId><ArticleId IdType="pubmed">23821375</ArticleId></ArticleIdList></Reference><Reference><Citation>Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis. 2010;2:1385&#x2013;1395. doi: 10.4155/Bio.10.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/Bio.10.103</ArticleId><ArticleId IdType="pubmed">21083339</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14:577&#x2013;589. doi: 10.1038/s41582-018-0058-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0058-z</ArticleId><ArticleId IdType="pubmed">30171200</ArticleId></ArticleIdList></Reference><Reference><Citation>Schippling S, et al. Global and regional annual brain volume loss rates in physiological aging. J Neurol. 2017;264:520&#x2013;528. doi: 10.1007/s00415-016-8374-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8374-y</ArticleId><ArticleId IdType="pubmed">28054131</ArticleId></ArticleIdList></Reference><Reference><Citation>Scahill RI, et al. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol-Chicago. 2003;60:989&#x2013;994. doi: 10.1001/archneur.60.7.989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.60.7.989</ArticleId><ArticleId IdType="pubmed">12873856</ArticleId></ArticleIdList></Reference><Reference><Citation>Barro C, et al. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain. 2018;141:2382&#x2013;2391. doi: 10.1093/brain/awy154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy154</ArticleId><ArticleId IdType="pubmed">29860296</ArticleId></ArticleIdList></Reference><Reference><Citation>Udtha M, et al. The Protection and Stabilization of Whole Blood at Room Temperature. Biopreserv Biobank. 2014;12:332&#x2013;336. doi: 10.1089/bio.2014.0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2014.0026</ArticleId><ArticleId IdType="pubmed">25340942</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankevich DE, Altevogt BM, Dunlop J, Gage FH, Hyman SE. Improving and Accelerating Drug Development for Nervous System Disorders. Neuron. 2014;84:546&#x2013;553. doi: 10.1016/j.neuron.2014.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.10.007</ArticleId><ArticleId IdType="pmc">PMC4254615</ArticleId><ArticleId IdType="pubmed">25442933</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams SR, McDade TW. The Use of Dried Blood Spot Sampling in the National Social Life, Health, and Aging Project. J Gerontol B-Psychol. 2009;64:I131&#x2013;I136. doi: 10.1093/geronb/gbn022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbn022</ArticleId><ArticleId IdType="pmc">PMC2763524</ArticleId><ArticleId IdType="pubmed">19244547</ArticleId></ArticleIdList></Reference><Reference><Citation>Koseoglu M, Hur A, Atay A, Cuhadar S. Effects of hemolysis interferences on routine biochemistry parameters. Biochem Med (Zagreb) 2011;21:79&#x2013;85. doi: 10.11613/BM.2011.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2011.015</ArticleId><ArticleId IdType="pubmed">22141211</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai SH, Cyrmanthey M. Effects of Hemolysis on Chemistry Tests. Lab Med. 1991;22:408&#x2013;410. doi: 10.1093/labmed/22.6.408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/labmed/22.6.408</ArticleId></ArticleIdList></Reference><Reference><Citation>Petzold A, et al. In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study. Brain. 2011;134:464&#x2013;483. doi: 10.1093/brain/awq360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq360</ArticleId><ArticleId IdType="pmc">PMC3030768</ArticleId><ArticleId IdType="pubmed">21278408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarra-Meneses AV, Mondal D, Alvar J, Moreno J, Carrillo E. Cytokines and chemokines measured in dried SLA-stimulated whole blood spots for asymptomatic Leishmania infantum and Leishmania donovani infection. Sci Rep. 2017;7:17266. doi: 10.1038/s41598-017-17315-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17315-z</ArticleId><ArticleId IdType="pmc">PMC5722824</ArticleId><ArticleId IdType="pubmed">29222521</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasawa K, et al. Human erythrocytes possess a cytoplasmic endoskeleton containing beta-actin and neurofilament protein. Arch Histol Cytol. 2006;69:329&#x2013;340. doi: 10.1679/aohc.69.329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1679/aohc.69.329</ArticleId><ArticleId IdType="pubmed">17372389</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasawa K, Taguchi T, Momota R, Naito I, Ohtsuka A. Intermediate filaments of endoskeleton within human erythrocytes. Blood. 2007;110:516a&#x2013;516a. doi: 10.1182/blood.V110.11.1734.1734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V110.11.1734.1734</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>